Evidence map›Paper›PMID 37534760›Full record

ArticleBrain pathology (Zurich, Switzerland)2023

Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation.

Hiroaki Miyahara, Chisato Tamai, Masanori Inoue, Kazuhito Sekiguchi, Daisuke Tahara, Nao Tahara, Kazuhiro Takeda, Shusei Arafuka, Hideyuki Moriyoshi, Ryuichi Koizumi and 6 more

Open access · goldAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Hiroaki MiyaharaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.ORCID 0000-0003-0723-0047
Chisato TamaiDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Masanori InoueDepartment of Pediatrics, Oita University Faculty of Medicine, Oita, Japan.
Kazuhito SekiguchiDepartment of Pediatrics, Oita University Faculty of Medicine, Oita, Japan.
Daisuke TaharaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Nao TaharaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Kazuhiro TakedaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Shusei ArafukaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Hideyuki MoriyoshiDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Ryuichi KoizumiDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Akio AkagiDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Yuichi RikuDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Jun SoneDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Kenji IharaDepartment of Pediatrics, Oita University Faculty of Medicine, Oita, Japan.
Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Aichi Medical University · JPOita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mitochondrial (m.) 3243A>G mutation is known to be associated with various mitochondrial diseases including mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Their clinical symptoms have been estimated to occur with an increased mitochondrial DNA (mtDNA) heteroplasmy and reduced activity of oxidative phosphorylation (OXPHOS) complexes, but their trends in the central nervous system remain unknown. Six autopsied mutant cases and three disease control cases without the mutation were enrolled in this study. The mutant cases had a disease duration of 1-27 years. Five of six mutant cases were compatible with MELAS. In the mutant cases, cortical lesions including a laminar necrosis were frequently observed in the parietal, lateral temporal, and occipital lobes; less frequently in the frontal lobe including precentral gyrus; and not at all in the medial temporal lobe. The mtDNA heteroplasmy in brain tissue samples of the mutant cases was strikingly high, ranging from 53.8% to 85.2%. The medial temporal lobe was preserved despite an inhospitable environment having high levels of mtDNA heteroplasmy and lactic acid. OXPHOS complex I was widely decreased in the mutant cases. The swelling of smooth muscle cells in the vessels on the leptomeninges, with immunoreactivity (IR) against mitochondria antibody, and a decreased nuclear/cytoplasmic ratio of choroidal epithelial cells were observed in all mutant cases but in none without the mutation. Common neuropathological findings such as cortical laminar necrosis and basal ganglia calcification were not always observed in the mutant cases. A high level of mtDNA heteroplasmy was observed throughout the brain in spite of heterogeneous cortical lesions. A lack of medial temporal lesion, mitochondrial vasculopathy in vessels on the leptomeninges, and an increased cytoplasmic size of epithelial cells in the choroid plexus could be neuropathological hallmarks helpful in the diagnosis of mitochondrial diseases.

Indexed as

MELAS SyndromeMitochondrial DiseasesDNA, MitochondrialHumansMitochondriaMutationNecrosisDNA, Mitochondrialchoroidal epithelial cell swellingMELASmitochondrial 3243A>G mutationmitochondrial vasculopathymtDNA heteroplasmystroke-like episodes

Identifiers

PMID37534760
PMCPMC10580013
OpenAlexW4385514001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.